SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001725160-22-000142
Filing Date
2022-08-01
Accepted
2022-08-01 17:28:17
Documents
1
Period of Report
2022-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165938928345083.html 4  
1 FORM 4 wf-form4_165938928345083.xml 4 4278
  Complete submission text file 0001725160-22-000142.txt   5794
Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Issuer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 65 HAYDEN AVENUE 2ND FLOOR LEXINGTON MA 02421
Business Address
Paul Andrea (Reporting) CIK: 0001863130 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39263 | Film No.: 221125971